Tim Murphy actually said...
In the face of these challenges, the FDA and the generic pharmaceutical industry have come together with other stakeholders to negotiate a historic 5-year agreement.
Context
Murphy discusses a new agreement aimed at improving drug approval processes.
02/08/2012